Background/Aims. This study investigated how HBV replication and host immune response are effected by reduced expression of TGF-β1 and HBx. Material and methods. Short interfering RNA (siRNA) knockdown technology has been used to examine the role of TGF-β1 in hepatitis B virus replication. The siTGF-β1 has been transfected along with 1.3mer HBV x-null to investigate the knockdown effect of TGF-β1 on HBV replication and host immune factors. Results. In this study, we found that diminished expression of TGF-β1 and increased expression of HBx enhances HBV replication several folds. The differential expression of TGF-β1 and HBx also stimulated transcriptional viral replicative intermediate (pgRNA) and secretion of core and 'e' antigen at translational level. Consequently, several cytokines such as IL-2, IL-8 and chemokine monocyte-chemoattractant protein (MCP-1) were increased significantly in response to stimulation of HBV replication. In contrast, TNF-α and RANTES mRNA expression increased insignificantly in response to enhanced HBV replication. Conclusions. We concluded that reduced expression of TGF-β1 together with HBx expression stimulate HBV replication and immune response, although the underlying mechanism of stimulation most likely differs.
ORIGINAL ARTICLE
ponse is responsible for both hepatocellular damage and viral clearance. 12, 13 Although the replicative phases have been studied in detail, the immunological manifestations are not completely understood.
HBV infected hepatocytes trigger early innate defense mechanisms in order to contain viral spread, although it has no role in disease pathogenesis and viral clearance. In contrary, adaptive immune responses play vital role in pathogenesis of liver injury and clearance of virus. [14] [15] [16] [17] Virus specific CD4+ Thelper cells and CD8+ cytotoxic T lymphocytes (CTLs) contribute to tissue damage and participate in viral clearance, either by killing infected cells or by producing soluble factors, such as chemokines and cytokines. [18] [19] [20] [21] [22] [23] These cytokines and chemokines play regulatory role involved in immune responses against viral infection and may directly inhibit viral replication. 23, 24 The TGF-β1 is a multifunctional cytokine involved in the regulation of growth and differentiation of both normal and transformed cells. 24 Additionally, it plays a pivotal role in modulating the immune response through the regulation of immune cells. 25 Several studies revealed that patients
INTRODUCTION
Hepatitis B virus (HBV) is the prototypic member of the hepadnavirus family and is a major cause of liver disease worldwide, ranging from acute to chronic to liver cirrhosis and hepatocellular carcinoma (HCC). [1] [2] [3] [4] The distinct cell populations of the liver, namely hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells, are arranged in highly organized manner. 5 The pathogenesis of HBV-induced liver diseases involves complicated mechanisms and implicates two important phases; viral replication and immune responses against HBV infection. [6] [7] [8] [9] [10] [11] During the infection of HBV, the host immune res-with chronic hepatitis and cirrhosis have significantly higher levels of plasma TGF-β1 compared to normal subjects. 26, 27 Recently, it has been reported that TGF-β1 may play an important role in regulating the progression of viral chronic hepatitis, cirrhosis, and carcinoma. [26] [27] [28] [29] [30] Similar to TGF-β1, HBV X gene (HBx), a multifunctional regulatory protein are suggested to play a critical role in HBV induced hepatocellular carcinoma. 31, 32 Recently, Chou, et al. showed suppressed HBV replication in presence of enhanced TGF-β1 level in the cultured cells and this decline was through preferential reduction of the synthesis of HBV pregenomic RNA (pgRNA) and core protein. 29 Our previous study demonstrated that five-fold decrease in HBV replication in absence of HBx through reduction of HBV pregenomic RNA (pgRNA) level. 33 These findings suggest that both TGF-β1 and HBx regulate HBV replication via pgRNA synthesis, although at different levels of their expressions. Therefore, we evaluated in vitro the differential level of TGF-β1 and HBx expression on the stimulation of HBV replication and host immune response elements.
MATERIAL AND METHODS

Cell culture and transfection
HepG2 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Gibco-BRL) and 10 µg gentamicin mL-1 at 37 °C in 5% CO 2 and passaged every third day. Briefly, cells were plated at 50-60% confluency. Cells were transfected using lipofectamine TM 2000 according to manufacturer's instruction.
Plasmids and small interfering RNA (si-RNA) sequence The 1.3mer overlength WT HBV-X null replicon construct (containing 1.3 units of the HBV genome spanning nt 1234-1978 of HBV ayw subtype) was prepared as described previously. 34 pCMV-HBx, a flag tagged HBx expression vector was generated by inserting a fragment encoding X-ORF in-frame into the p3XFLAG-CMV-14 plasmid (sigma). siTGF-β1 was obtained from Dharmacon, Inc. having siTGFb1 sense sequence CCA GAA AUA CAG CAA CAA UUU and siTGF-β1 anti-sense sequence AUU GUU GCU GUA UUU CUG GUU. The scramble sequence was as follows:
• Sense: AAGTCGAGTCGCGTATGCAGGCCTGT CTC.
• Anti-sense: AACCTGCATACGCGACTCGACCCT GTCTC.
HepG2 cells were transfected with 40 nM siRNA using lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. The knockdown efficiency of siTGF-β1 was tested along with scrambled (siSCR) by western blot (Figure 1 ).
Transfection
To examine the effects of siTGF-β1 on HBV replication and host immune cytokines, cells were transfected in three different dishes with different combinations. For transfection, cells were grown in 100 mm dishes and transfected as follows:
• Dish 1: 1.3mer HBV WT X-null+ siSCR.
• Dish 2: 1.3mer HBV WT X-null+ HBx.
• Dish 3: 1.3mer HBV WT X-null+ siTGF-β1.
Extraction of viral DNA and southern blot
Viral DNA from cytoplasmic capsids was isolated from HepG2 cells at 4 days post-transfection, as described previously. 35 Southern blot analysis was performed as described previously. 36 Briefly, the extracted viral DNA was separated by electrophoresis through a 1.3% agarose gel in 0.5 x Tris/acetate/EDTA buffer and transferred onto a nylon membrane. The membrane was pre-hybridized and then hybridized with a 32P- labelled full-length HBV DNA probe in hybridization solution for 16 h at 65 °C. Images were obtained using a PhosphorImager (BAS-2500; Fujifilm).
RNase protection assay (RPA)
RNA extraction was performed as described above in the primer-extension assay 37 and an RPA was performed essentially as described previously. 38 The riboprobe was derived from the core region (nt 1903-2140) of the promoter as described previously 34 Briefly, samples of total RNA or core-associated RNA (30 µg) were hybridized for 16 h at 42 °C with two probes labelled with [α-32 P]UTP (3,000 Ci mmol-1; Amersham). RNase digestions were carried out with a mixture of RNase A and RNase T1 (Ambion) at 37 °C for 30 min. The digested products were separated on a 6% acrylamide/8 M urea gel, which was dried and imaged using a Phosphor-Imager.
Detection of Core and 'e' antigen by ELISA
The amount of HBV core (HBcAg) and 'e' (HBeAg) secreted into the culture supernatant was measured in all above experimental condition by enzyme-linked immunosorbent assay (ELISA) kit according to manufacturer's protocol (DiaSorin, UK). Each experiment was performed in triplicate and repeated 3 times independently.
Gene expression by end point and real time PCR
Total cellular RNA from three different dishes was extracted using Trizol (Invitrogen, Life Tech- nologies) according to the manufacturer's protocol. Two micrograms of total RNA was used to synthesize cDNA using high capacity RNA to cDNA kit (Applied Biosystem). The end point PCR was used to check the mRNA expression of different host cytokines and chemokines. To confirm the end point PCR findings, real time PCR was performed using SYBR Green qPCR master mix method (Applied Biosystem) in a 7500 Real Time PCR System (Applied Biosystem).The experiments were repeated in triplicates. The real time primers sequence of each gene is provided in table 1.
Statistical analysis
A two tailed Student's t-test, assuming unequal variances, was used for all statistical analyses; a P value of < 0.05 was considered statistically significant.
RESULTS
TGF-β β1 knockdown enhances HBV replication
To determine the effect of TGF-β1 knockdown on HBV replication, HepG2 cells were co-transfected with 1.3 mer HBV X-null replicon along with siT-GF-β1 and siSCR. Southern blot analysis indicated that TGF-β1 knockdown significantly enhances HBV replication (Lane 3) compared to scrambled (Figure 2, lane 1 vs. lane 3) . The fold increase in HBV replication by TGF-β1 knockdown was almost 
TGF-β β1 knockdown enhances HBV replication through increase in pgRNA level
Previously, we reported that wild type HBx complemented with 1.3 mer HBV X-null facilitates viral pregenomic RNA (pgRNA) transcription by approximately five fold compared to full length HBV x-null construct. To clarify, whether knockdown of TGF-β1 resulted in pgRNA stimulation at transcriptional level, RNase protection assay was performed. Total and capsid-associated viral transcripts were isolated from the cytoplasm. RPA of total cytoplasmic RNA revealed that the amount of pregenomic RNA from cells transfected with 1.3 mer HBV X-null+ siTGF-β1 was enhanced by approximately fivefold relative to that of the 1.3mer HBV X-null +siSCR (Figure 3 , lane 1 and 2 vs. lane 5 and 6). Thus it was consistent with the interpretation that TGF-β1 knockdown contributes to viral genome replication entirely at the transcriptional level and hence antagonistic to HBx action.
TGF-β β1 knockdown enhances HBcAg and HBeAg
We then assessed the impact of TGF-β1 knockdown on the secretion of core and 'e' antigen into culture medium of cells by commercially available ELISA kit. This was done in order to find the level of core and 'e' antigen secretion from transfected 1.3 mer HBV X-null in presence of siTGF-β1 and HBx. Consistent with the above transcriptional level data, both core and 'e' antigen secreted in culture medium were increased to 2-3 fold in presence of siTGF-β1 and HBx (Figures 4A and 4B) .
Effect of siTGF-β1 knockdown on gene expression involved in host immune response TGF-β1is a secreted protein that performs many cellular functions and are involved in stimulatory as well as inhibitory effects in different cell types. It also play an important role in regulating the immune mechanism of the host cells. Therefore we tested; if knockdown of TGF-β1 expression in HBV replicating cells affect the level of immune cytokines and chemokines mRNA (such as IL-8, IL-2, TNF-α, RANTES and MCP-1) that regulates viral clearance. Reverse transcription-PCR (end point PCR) was performed using specific primers for each gene to identify the mRNA expression level and were reconfirmed by real time quantitative PCR. As shown in figures 5A and 5B, siTGF-β1 and HBx induced expression of both interleukin-8 (IL-8) and interleukin-2 (IL-2) to a significant level. Similarly, siTGF-β1 and HBx action upregulated the mRNA expression of TNF-α, but to a insignificant level compared to 1.3mer X null+ siSCR transfected ( Figure 5C ). The expression of the monocyte-chemoattractant protein (MCP-1), a chemokine increases to a significant level in presence of siTGF-β1 and HBx compared to1.3mer X null+ siSCR ( Figure 5D ), while another important chemokine (RANTES) level increased but insignificantly ( Figure 5E ). red with knockdown (minus) Huh7 cells. The expression level of TNF-a and RANTES too increased in TGF-β1 knockdown cells but not to a significant level. The level of cytokines and chemokines imitate TGF-β1 knockdown cells, when HBx complement with 1.3 mer HBV X-null. The augmented cytokines level may be due to increase HBV replication in knockdown cells, and are likely to be involved in the regulation of immune responses against viral infection and may directly inhibit viral replication. 42 Therefore, in absence or low level of TGF-β1 may trigger cascades of antiviral responses involving cytokine and chemokines. Although, HBx increases HBV replication by several folds, we speculate that it has adjunct role in chronicity. The host defence machinery (including chemokines and cytokines) play a vital role in determining the viral clearance and persistence.
CONCLUSION
The differential expression of TGF-β1 and HBx stimulate HBV replication and immune response, although the underlying mechanism of stimulation most likely differs. We speculate that the activity of TGF-β1 and HBx vary among different hosts and hence the disease outcome.
